Singapore, Singapore, January 7th, 2026, FinanceWire
Boyang Wang, founder of the venture capital firm Immortal Dragons, has announced a bold vision for the future of human life extension, leveraging Singapore’s unique regulatory and investment landscape to accelerate “moonshot” projects. In a recent feature on the Financial Times’ “Tech Tonic” podcast, Boyang detailed his firm's strategy, which includes funding research into concepts as ambitious as creating “brainless clones” for organ and brain transplantation.
Immortal Dragons is positioning itself at the forefront of the longevity industry by capitalizing on what Boyang terms "regulatory arbitrage"—the ability to conduct research that would be prohibitively difficult or expensive elsewhere. He argues that Singapore offers a crucial advantage for pioneering research that faces significant hurdles in Western countries. This strategic positioning enables the firm to invest in high-risk, high-impact projects that could redefine the boundaries of human lifespan and reshape the future of medicine. Boyang pointed to primate studies as a key example, noting that while such research requires extensive approval processes and substantial funding in the United States, Asian jurisdictions maintain more lenient regulatory frameworks, enabling ambitious scientific exploration that pushes the boundaries of what is currently possible.
Boyang’s firm is dedicated to funding projects that push the limits of current scientific understanding. The most striking of these is the exploration of artificially induced hydranencephaly—a condition where infants are born without a developed cerebral cortex—to create what he calls “brainless clones.” These could serve as a source for organ transplantation or even, in a more speculative future, for brain transplantation.
“Imagine if we can do a brain transplant, then this new body can become our second home,” Boyang stated on the podcast, acknowledging that the concept is well beyond the current scientific consensus. This forward-looking investment philosophy underscores his commitment to pursuing breakthroughs that could fundamentally alter human existence.
The announcement comes as Singapore solidifies its reputation as a global epicenter for longevity research. A combination of government initiatives focused on extending "healthspan" rather than merely lifespan, coupled with substantial research funding and Singapore's strategic location bridging East and West, has created a fertile ecosystem for leading scientists and investors. The Financial Times' report highlighted this convergence of government investment, technological ambition, and regulatory leniency as the driving force behind the nation's emergence as a testing ground for some of humanity's most ambitious—and controversial—attempts to extend life.
However, this rapid progress is not without its challenges. The podcast featured cautionary perspectives from experts like Andrea Meyer, a physician and researcher at the National University of Singapore, who notes that the longevity field often skips diagnosis and moves directly to radical interventions—something that would be malpractice in conventional oncology. Chet Lim, a 53-year-old fitness entrepreneur dubbed Singapore's "Benjamin Button," champions a more measured approach, focusing on eliminating "disease span" rather than merely extending lifespan. Host Hannah Kuchler raised concerns about the lack of standardized biomarkers and adequate oversight, warning that vulnerable populations—the elderly, the health-anxious—may spend substantial sums on unproven treatments.
About Immortal Dragons
Immortal Dragons (https://www.id.life/) is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, high-impact technologies and currently supports more than 15 portfolio companies. Beyond conventional investments, the fund advances longevity advocacy through book translation and publishing, translation of longevity leaders’ talks, hosting a leading Chinese-language longevity podcast, and providing sponsorships and grants to longevity initiatives and conferences.
For Press Inquiries
Boyang Wang
Founder, Immortal Dragons
press@id.life
Contact
Boyang Wangpress@id.life
